These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

63 related articles for article (PubMed ID: 1356721)

  • 1. Metabolism of the leukotriene receptor antagonist 5-(2-(8-phenyloctyl)phenyl)-4,6-dithianonanedioic acid (SK&F 102922) in the guinea pig. Rearrangement of the acyl glucuronide.
    Newton JF; Straub KM; Dewey RH; Perchonock CD; McCarthy ME; Gleason JG; Lynn RK
    Drug Metab Dispos; 1992; 20(4):479-84. PubMed ID: 1356721
    [TBL] [Abstract][Full Text] [Related]  

  • 2. In vivo metabolism of the leukotriene receptor antagonist, 5-(2-dodecylphenyl)-4,6-dithianonanedioic acid (SK&F 102,081) in the guinea pig.
    Newton JF; Straub KM; Kuo GY; Perchonock CD; McCarthy ME; Gleason JG; Lynn RK
    Drug Metab Dispos; 1987; 15(2):168-76. PubMed ID: 2882973
    [TBL] [Abstract][Full Text] [Related]  

  • 3. In vitro microsomal metabolism of the leukotriene receptor antagonist, 5-(2-dodecylphenyl)-4,6-dithianonanedioic acid (SK&F 102,081).
    Newton JF; Straub KM; Dewey RH; Perchonock CD; Leonard TB; McCarthy ME; Gleason JG; Eckardt RD
    Drug Metab Dispos; 1987; 15(2):161-7. PubMed ID: 2882972
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The bronchopulmonary pharmacology of SK&F 104353 in anesthetized guinea pigs: demonstration of potent and selective antagonism of responses to peptidoleukotrienes.
    Torphy TJ; Newton JF; Wasserman MA; Vickery-Clark L; Osborn RR; Bailey LS; Yodis LA; Underwood DC; Hay DW
    J Pharmacol Exp Ther; 1989 May; 249(2):430-7. PubMed ID: 2542530
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Antagonism of leukotriene C4, leukotriene D4 and leukotriene E4 vasoconstrictor responses in the conscious rat with the peptidoleukotriene receptor antagonist SK&F 104353: evidence for leukotriene D4 receptor heterogeneity.
    Smith EF; Slivjak MJ; Eckardt RD; Newton JF
    J Pharmacol Exp Ther; 1989 Jun; 249(3):805-11. PubMed ID: 2543811
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Pharmacologic profile of SK&F 104353: a novel, potent and selective peptidoleukotriene receptor antagonist in guinea pig and human airways.
    Hay DW; Muccitelli RM; Tucker SS; Vickery-Clark LM; Wilson KA; Gleason JG; Hall RF; Wasserman MA; Torphy TJ
    J Pharmacol Exp Ther; 1987 Nov; 243(2):474-81. PubMed ID: 2824747
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Concentration-dependent, stereoselective inhibition of the endotoxin-induced hemoconcentration in conscious rats with the peptidoleukotriene receptor antagonist SK & F 104353.
    Smith EF; Kinter LB; Jugus M; Eckardt RD; Newton JF
    Eicosanoids; 1989; 2(2):101-7. PubMed ID: 2560662
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Metabolic profiles of montelukast sodium (Singulair), a potent cysteinyl leukotriene1 receptor antagonist, in human plasma and bile.
    Balani SK; Xu X; Pratha V; Koss MA; Amin RD; Dufresne C; Miller RR; Arison BH; Doss GA; Chiba M; Freeman A; Holland SD; Schwartz JI; Lasseter KC; Gertz BJ; Isenberg JI; Rogers JD; Lin JH; Baillie TA
    Drug Metab Dispos; 1997 Nov; 25(11):1282-7. PubMed ID: 9351905
    [TBL] [Abstract][Full Text] [Related]  

  • 9. SKF 104353, a high affinity antagonist for human and guinea pig lung leukotriene D4 receptor, blocked phosphatidylinositol metabolism and thromboxane synthesis induced by leukotriene D4.
    Mong S; Wu HL; Miller J; Hall RF; Gleason JG; Crooke ST
    Mol Pharmacol; 1987 Aug; 32(1):223-9. PubMed ID: 3039338
    [TBL] [Abstract][Full Text] [Related]  

  • 10. pH-dependent rearrangement of the biosynthetic ester glucuronide of valproic acid to beta-glucuronidase-resistant forms.
    Dickinson RG; Hooper WD; Eadie MJ
    Drug Metab Dispos; 1984; 12(2):247-52. PubMed ID: 6144492
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Metabolic formation of N- and O-glucuronides of 3-(p-chlorophenyl)thiazolo[3,2-a]benzimidazole-2-acetic acid. Rearrangement of the 1-o-acyl glucuronide.
    Janssen FW; Kirkman SK; Fenselau C; Stogniew M; Hofmann BR; Young EM; Ruelius HW
    Drug Metab Dispos; 1982; 10(6):599-604. PubMed ID: 6130907
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Synthesis and pharmacological characterization of 5-(2-dodecylphenyl)-4,6-dithianonanedioic acid and 5-[2-(8-phenyloctyl)phenyl]-4,6-dithianonanedioic acid: prototypes of a novel class of leukotriene antagonists.
    Perchonock CD; McCarthy ME; Erhard KF; Gleason JG; Wasserman MA; Muccitelli RM; DeVan JF; Tucker SS; Vickery LM; Kirchner T
    J Med Chem; 1985 Sep; 28(9):1145-7. PubMed ID: 2993610
    [No Abstract]   [Full Text] [Related]  

  • 13. Binding of radiolabeled high affinity antagonist to leukotriene D4 receptor in guinea pig lung membranes: interconversion of agonist-receptor binding affinity states.
    O'Sullivan BP; Mong S
    Mol Pharmacol; 1989 Jun; 35(6):795-802. PubMed ID: 2543913
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Species differences in the elimination of a peroxisome proliferator-activated receptor agonist highlighted by oxidative metabolism of its acyl glucuronide.
    Kochansky CJ; Xia YQ; Wang S; Cato B; Creighton M; Vincent SH; Franklin RB; Reed JR
    Drug Metab Dispos; 2005 Dec; 33(12):1894-904. PubMed ID: 16183782
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Disposition and covalent binding of diflunisal and diflunisal acyl glucuronide in the isolated perfused rat liver.
    Wang M; Dickinson RG
    Drug Metab Dispos; 1998 Feb; 26(2):98-104. PubMed ID: 9456294
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Characterization of the metabolites of the peptidomimetic human immunodeficiency virus type 1 protease inhibitor SK&F 107461 in rats using liquid chromatography/mass spectrometry.
    Potts W; van Horn R; Anderson K; Blake T; Garver E; Joseph G; Dreyer G; Shu A; Heys R; Fong KL
    Drug Metab Dispos; 1995 Aug; 23(8):799-805. PubMed ID: 7493545
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Absorption, metabolism, and excretion of [(14)C]MK-0524, a prostaglandin D(2) receptor antagonist, in humans.
    Karanam B; Madeira M; Bradley S; Wenning L; Desai R; Soli E; Schenk D; Jones A; Dean B; Doss G; Garrett G; Crumley T; Nirula A; Lai E
    Drug Metab Dispos; 2007 Jul; 35(7):1196-202. PubMed ID: 17431030
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Furosemide 1-O-acyl glucuronide. In vitro biosynthesis and pH-dependent isomerization to beta-glucuronidase-resistant forms.
    Rachmel A; Hazelton GA; Yergey AL; Liberato DJ
    Drug Metab Dispos; 1985; 13(6):705-10. PubMed ID: 2867875
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Pharmacologic profile of SK&F 104353, a novel, highly potent and selective peptidoleukotriene antagonist.
    Wasserman MA; Torphy TJ; Hay DW; Muccitelli RM; Tucker SS; Wilson KA; Osborn RR; Vickery-Clark L; Hall RF; Erhard KF
    Adv Prostaglandin Thromboxane Leukot Res; 1987; 17A():532-5. PubMed ID: 2821765
    [No Abstract]   [Full Text] [Related]  

  • 20. Interaction of human serum albumin with the electrophilic metabolite 1-O-gemfibrozil-beta-D-glucuronide.
    Sallustio BC; Fairchild BA; Pannall PR
    Drug Metab Dispos; 1997 Jan; 25(1):55-60. PubMed ID: 9010630
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 4.